COVID-19

HENRY FORD STUDY: Hydroxychloroquine reduces mortality in COVID-19 patients.

#covid19 #hydroxychloroquine #henryford
Henry Ford Hospital health system published a study showing that Hydroxychloroquine reduces mortality in COVID-19 patients when monitored for cardiac side effects and when the treatment is started within 24-48 hours after admission.

Reference: